logo
15:31 May 29

Sotac Pharmaceuticals Ltd

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
111.00
+0.00 (+0.00%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Sotac Pharmaceuticals Ltd Financials

Sotac Pharmaceuticals Ltd
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
111.00
+0.00 (+0.00%)
15:31 May 29
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

37/100
Mid Valuation

Technical

39/100
Technically Neutral

Strength

5

Weakness

1

Opportunity

0

Threats

0

10.68 %

ROE %

4.71 %

ROA %

5.70

EPS

53.28

BVPS

6.21 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
73.15 77.48 103.83 96.99 101.24
Operating Expenses +
67.02 70.23 95.32 83.34 83.35
Raw Material
56.43 61.68 80.38 64.26 65.32
Increase Decrease in Cost
-0.45 -4.41 -0.76 4.05 -0.81
Other Manufacturing Expense
3.84 0 0 0 0
Employee Cost
2.98 4.23 4 3.17 3.68
Miscellaneous Expenses
4.76 9.79 16.94 14.52 34.74
Operating Profit
6.13 7.25 8.51 13.65 17.89
Other Income
0.22 0.35 0.49 3.9 0.35
Depreciation
1.13 2.28 3.1 3.84 5.41
Interest
0.53 1.98 1.7 2.58 4.13
Profit before tax and exceptio..
4.69 3.35 4.2 11.12 8.7
Exceptional Items
0 0.58 -0.23 0 0
PBT
4.69 3.93 3.96 11.12 8.7
Provision for Taxation
1.82 1.64 0.38 1.84 2.4
Net Profit
2.88 2.29 3.58 9.28 6.29
NET Profit after MI
2.88 2.29 4.28 8.03 6.29
EPS
12.51 2.84 3.9 7.26 5.22
Operating Profit Margin (%)
8.38 9.36 8.2 14.07 17.67
Net Profit Margin (%)
3.94 2.96 4.12 8.28 6.21

Sotac Pharmaceuticals Ltd Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Mar 2025 Sep 2025 Mar 2026
Promoter 72.80 72.80 72.80 72.80
FII 16.80 16.10 15.10 8.90
Public 0.00 0.00 0.70 0.00
Others 10.40 11.10 11.40 18.30
Shareholder Shares Holding %
Research 360 logo
Download Our App On: